Evaluation of combined therapy in carcinoma of the bladder

A number of studies are considered in order to evaluate the benefits of combined treatment for patients with Stage B2C transitional carcinoma of the bladder. It is found that for a variety of reasons, such treatment is not shown to be beneficial; the conclusion is that routine combined preoperative therapy is investigative but cannot be recommended as a community standard.